Aline G. Santana

Aline G. Santana

Auto-generated profile, based on publicly available information

Aline G. Santana

Brazilian Biosciences National Laboratory (LNBio) Brazilian Center for Research in Energy and Materials (CNPEM) Campinas São Paulo 13083‐970 Brazil

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2021 in Chemistry of Materials
Verified
Journal Article
Closed access
LTLuciana D. Trino
Luciana D. Trino
LALuiz G. S. Albano
Luiz G. S. Albano
DGDaniela C. Granato
Daniela C. Granato
ASAline G. Santana
Aline G. Santana
DCDavi H. S. de Camargo
Davi H. S. de Camargo
ALAdriana F. Paes Leme
Adriana F. Paes Leme

29 July 2025 in Small
Verified
Journal Article
Open access
LALuciana D. Trino Albano
Luciana D. Trino Albano
DGDaniela C. Granato
Daniela C. Granato
LALuiz G. S. Albano
Luiz G. S. Albano
FPFábio Patroni
Fábio Patroni
ASAline G. Santana
Aline G. Santana
ALAdriana F. Paes Leme
Adriana F. Paes Leme
Early detection of oral squamous cell carcinoma (OSCC) significantly enhances treatment outcomes and survival rates, with lymph node metastasis serving as a main prognostic factor. However, current clinical practices rely on TNM classification, including histological confirmation of metastatic disease in lymph nodes, often involving elective neck dissection, a procedure that can cause post‐operative morbidity. Here it is shown that zinc imidazole framework‐8 (ZIF‐8) electrochemical biosensors can effectively distinguish non‐metastatic (N0) from lymph node metastatic (N+) OSCC saliva samples. By monitoring the OSCC biomarkers cystatin B (CSTB), leukotriene A 4 hydrolase (LTA4H), and collagen type VI alpha 1 chain (COL6A1) in human saliva through electrochemical impedance spectroscopy and antigen–antibody immunoreactions, elevated biomarker levels in N0 samples are observed. The biosensor displays high accuracy, specificity, and reproducibility, with limits of detection lower than 0.4 ng mL −1 . Supervised bioinformatic analysis, using 34 machine learning classifiers, indicates LTA4H as the most accurate biomarker for distinguishing prognostic groups, confirming previous mass spectrometry findings. Notably, the AdaBoost model, integrating the combined detection of biomarkers, achieves a 76% accuracy rate in identifying metastatic saliva samples. This non‐invasive biosensor technology, combined with bioinformatics, presents a sensitive and reliable approach to improve clinical assessments and guiding therapeutic decisions for OSCC patients.

28 June 2017
Verified
Book Chapter
Closed access
PDF file
ASAline G. Santana
Aline G. Santana
GZGiuliana S. Zuccoli
Giuliana S. Zuccoli
VSVerônica M. Saia-Cereda
Verônica M. Saia-Cereda
JCJuliana Silva Cassoli
Juliana Silva Cassoli
DMDaniel Martins-de-Souza
Daniel Martins-de-Souza